← Eichor
Condition: Medications For Opioid Use Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Medications For Opioid Use Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NA · 1 location(s) · Emory University · NCT05711056Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
NA · 1 location(s) · Potomac Health Foundations · NCT06774248Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826Longitudinal Neural Fingerprinting of Opioid-use Trajectories
NA · 1 location(s) · Yale University · NCT06207162Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Diso
NA · 1 location(s) · Geisinger Clinic · NCT07197801Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department
NA · 1 location(s) · University of Vermont · NCT07129902Towards Testing the Effectiveness of Recovery Community Centers (RCCs)
NA · 1 location(s) · Massachusetts General Hospital · NCT07010978Injectable Buprenorphine in Prison: A Preference Trial
Phase 4 · 1 location(s) · Lifespan · NCT06880718Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation
NA · 1 location(s) · Baystate Medical Center · NCT06527820Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD
NA · 1 location(s) · Ohio State University · NCT06718491CEDRN: Opioid Registry
Phase N/A · 1 location(s) · University of British Columbia · NCT07466784Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication
Phase 2 · 1 location(s) · University of British Columbia · NCT05585229The Youth Opioid Recovery Support (YORS) Intervention
NA · 1 location(s) · Potomac Health Foundations · NCT04173416Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implica
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT06104280Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
Phase 4 · 1 location(s) · University of Connecticut · NCT05669534Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treat
Phase 2 · 1 location(s) · Washington State University · NCT06323837Emergency Medicine Peer Outreach Worker Engagement for Recovery
Phase N/A · 1 location(s) · University of California, Los Angeles · NCT06320015Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment
NA · 1 location(s) · University of Arkansas · NCT07071766Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial
Phase 4 · 2 location(s) · Pouya Azar · NCT07439549Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
NA · 1 location(s) · Medical University of South Carolina · NCT06157840Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic
Phase N/A · 1 location(s) · Boston University · NCT07232641Young Houston Emergency Opioid Engagement System
Phase 4 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT04811014Mindfulness Texting for Medication Adherence and Chronic Pain Management
NA · 1 location(s) · University of New Mexico · NCT07711795Acetazolamide in Central Sleep Apnea Patients Using Medication for Opioid Use Disorder
Phase 2 · 1 location(s) · Sanjay R Patel · NCT06521476Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
Phase 4 · 6 location(s) · Yale University · NCT06323824Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
NA · 1 location(s) · Medical University of South Carolina · NCT06999811Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
NA · 1 location(s) · University of Washington · NCT06593353Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
NA · 1 location(s) · Boston Medical Center · NCT06732596Opioid Treatment and Peer Recovery Support
NA · 3 location(s) · Brown University · NCT04978168PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
NA · 2 location(s) · Boston Medical Center · NCT05769218
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.